Neurodevelopmental delays and disabilities are the most frequent and significant consequences of congenital heart disease (CHD) and its treatment.
1 Improvements in surgical techniques and medical support have reduced mortality and morbidity rates, including overt neurological injury (eg, seizure, coma, death) from 50% to 2.3%.
2,3 However, sensitive magnetic resonance imaging studies have identified clinically silent, new brain injuries as small focal white matter lesions or strokes in more than 60% of newborns who undergo surgical treatment.
4,5 Consistent with the focal nature of these injuries, cognitive deficits at school age are mild, with mean IQs reported in the low end of the reference range.
6 However, children with CHD exhibit deficits in multiple neurodevelopmental domains, including speech and language, attention, memory, executive function, visual-spatial skills, and gross and fine motor function, suggesting a more global injury not resolved by magnetic resonance imaging. This high prevalence of low-severity anomalies has been termed the
neurodevelopmental signature of CHD.
7 Long-term consequences include prevalent behavioral problems and the need for remedial academic services.
8 However, a meta-analysis of major surgical intervention trials to improve neurodevelopmental outcomes found that none were successful. Therefore, actionable perioperative factors are lacking to improve neurodevelopmental outcomes in neonates with CHD.
9,10